Envoy Medical receives Nasdaq deficiency notice for low market value of listed securities

Envoy Medical, Inc.

Nasdaq notified Envoy Medical on Feb 25, 2025 that market value of listed securities fell below $35M for 31 consecutive business days.
Company has 180 days, until Aug 25, 2025, to regain compliance by having MVLS exceed $35M for 10 consecutive business days.
Failure to regain compliance could result in delisting from Nasdaq.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.